-
One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids
Study
EGAS00001006886
-
Separation of chronic myeloid leukemia stem cells from normal hematopoietic stem cells at single-cell resolution
Study
EGAS00001006904
-
Molecular features of adenomas predicting metachronous colorectal cancer: a nested-case control study
Study
EGAS00001007039
-
Proteomic Analysis of Non-Muscle Invasive and Muscle Invasive Bladder Cancer Highlights Distinct Subgroups With Metabolic, Matrisomal, and Immune Hallmarks
Study
EGAS00001007290
-
A circulating biomarker for severity of facioscapulohumeral muscular dystrophy
Study
EGAS00001007350
-
Raw bulk TCRseq data fromTIL and non-TIL expanded TRACERx samples in the manuscript Bulk TCRseq from TRACERx samples from 'Subclonal immune evasion in non-small cell lung cancer'
Study
EGAS00001008118
-
Single cell TCRseq data fromTIL and non-TIL expanded TRACERx samples in the manuscript Bulk TCRseq from TRACERx samples from 'Subclonal immune evasion in non-small cell lung cancer'
Study
EGAS00001008161
-
RNAseq dataset for MALT1 in MCL
Dataset
EGAD00001009771
-
Dataset for Sarcoma RNA sequencing linked from study EGAS00001004813
Dataset
EGAD00001010276
-
Solve-RD_RND_cohort-1_DF1+2_V1
Dataset
EGAD00001009769
-
Molecular characterization of Barrett’s esophagus at single cell resolution
Study
EGAS00001005221
-
Genome-wide DNA methylation sequencing identifies epigenetic perturbations in the upper airways under long-term exposure to moderate levels of ambient air pollution
Study
EGAS00001007374
-
Procardis study on novel susceptibility genes for coronary artery disease (CAD)
Study
EGAS00000000055
-
Wellcome Trust Sanger Institute
Dac
EGAC00001000205
-
Knoll et al.: The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation
Study
EGAS00001007461
-
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
Study
EGAS50000000168
-
B cell receptor silencing reveals origin and dependencies of high-grade B cell lymphomas with MYC and BCL2 rearrangements
Study
EGAS50000001047
-
Expanding the SPTBN1 Spectrum: A Case of Neurodevelopmental Disorder with GI and Musculoskeletal Involvement
Study
EGAS50000001213
-
German early-onset prostate cancer cohort of the Pan-Prostate Cancer Genome (PPCG) project
Study
EGAS00001003373
-
Ancient Yakuts genomes and metagenomes
Dataset
EGAD50000001903
-
METABRIC
Study
EGAS00000000083
-
UK10K NEURO IOP COLLIER
Study
EGAS00001000121
-
UK10K NEURO GURLING
Study
EGAS00001000225
-
Therapeutic Resistance to PI3K-alpha Inhibitors
Study
EGAS00001000991
-
Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study
Study
EGAS00001001709
-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666
-
Automated machine-learning approach for next generation profiling of sequence alterations, mutation burden, microsatellite instability, and structural variants in human cancers
Study
EGAS00001005556
-
Foundation Medicine Genomic Data Used to Identify Prognostic Markers and Fusion Genes in Multiple Myeloma
Study
EGAS00001002874
-
Scottish High Grade Serous Ovarian Cancer
Study
EGAS00001004410
-
Germline elongator mutations in sonic hedgehog medulloblastoma
Study
EGAS00001004126
-
Gene expression-based prediction of pazopanib efficacy in sarcoma (HIPO, H021)
Study
EGAS00001005836
-
APOBEC mutagenesis is a common process in normal human small intestine
Dataset
EGAD00001008764
-
Evolution and clinical impact of genetic epistasis within EGFR-mutant lung cancers
Study
EGAS00001002604
-
Identifying transcriptional programs underlying anti-EGFR small molecule response and resistance with TraCe-seq
Study
EGAS00001005405
-
Characterization of Cell Free Plasma Methyl-DNA From Xenografted Tumors to Guide the Selection of Diagnostic Markers for Early-Stage Cancers
Study
EGAS00001006175
-
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
Study
EGAS00001006059
-
HCA_Thymus_Disease_DiGeorge_Transplant_RNA
Study
EGAS00001004025
-
High-resolution testing of ctDNA dynamics predicts survival in metastatic NSCLC
Study
EGAS00001006703
-
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial
Study
EGAS00001006838
-
TK-EPN862 - Patient-dervied xenograft model of Posterior Fossa A Ependymoma - RNAseq
Study
EGAS00001006844
-
Effects of 2DG, Galactose, or Oligomycin on the epigenome remodeling induce by T cells activation.
Study
EGAS00001007115
-
Mapping the epigenomic landscape of human monocytes following innate immune activation reveals context-specific mechanisms driving endotoxin tolerance
Study
EGAS00001007362
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – Whole exome sequencing
Study
EGAS00001004832
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – RNA sequencing
Study
EGAS00001004833
-
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions(H021/INF)
Study
EGAS00001006939
-
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Study
EGAS00001007077
-
The Haemgen RBC study
Study
EGAS00000000132
-
Warm_autopsy__mutational_signatures_and_clonal_units
Study
EGAS00001002216
-
SABE_1171_WGS_GVCF_IDX
Dataset
EGAD00001008203